CLAVAMOXY 625 LB : Key Ingredients and Benefits , Indications for Use , Where to buy Etc...

CLAVAMOXY 625 LB  
Amoxicillin Potassium Clavulanate and Lactic Bacillus Tablets

CLAVAMOXY 625 LB is a unique combination tablet containing Amoxicillin Potassium Clavulanate alongside Lactic Bacillus, offering a dual-action approach to combat bacterial infections while promoting gut health. Explore the features and benefits of CLAVAMOXY 625 LB for effective and holistic treatment.

Key Features and Benefits:

1. Antibiotic Potency: CLAVAMOXY 625 LB combines the broad-spectrum antibiotic activity of Amoxicillin Potassium Clavulanate to target a wide range of bacterial infections, including respiratory, urinary tract, and skin infections.

2. Beta-Lactamase Inhibition: Potassium Clavulanate in CLAVAMOXY 625 LB inhibits bacterial beta-lactamase enzymes, extending Amoxicillin's spectrum of activity and enhancing its efficacy against beta-lactamase-producing bacteria.

3. Probiotic Support: The inclusion of Lactic Bacillus in CLAVAMOXY 625 LB promotes gut health by restoring the balance of beneficial bacteria in the digestive system, reducing the risk of antibiotic-associated gastrointestinal disturbances.

4. Comprehensive Therapy: CLAVAMOXY 625 LB offers comprehensive therapy by addressing both the infection and potential gastrointestinal side effects associated with antibiotic use, leading to improved patient comfort and adherence to treatment.

Indications and Usage:

CLAVAMOXY 625 LB is indicated for the treatment of bacterial infections requiring a broad-spectrum antibiotic along with probiotic support.

Dosage and Administration:

Healthcare providers determine the appropriate dosage of CLAVAMOXY 625 LB based on the type and severity of the infection. Patients should follow the prescribed dosing schedule and complete the full course of treatment.

Safety Considerations:

• Patients should inform their healthcare provider about any allergies, medical conditions, or medications they are taking before starting CLAVAMOXY 625 LB to prevent potential adverse reactions or interactions.
• Regular monitoring during treatment with CLAVAMOXY 625 LB ensures optimal therapeutic outcomes and minimal side effects.

Conclusion:

CLAVAMOXY 625 LB offers a synergistic combination of antibiotic potency and probiotic support, making it a valuable choice for treating bacterial infections while promoting gastrointestinal health. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW